Skip to content

Renal Osteodystrophy

Renal osteodystrophy is the bone component of chronic kidney disease–mineral and bone disorder. Abnormal phosphate, calcium, vitamin D and parathyroid hormone signalling can alter bone turnover and strength.

Rocaltrol

Calcitriol

0.25mg

Formulated to target calcium metabolism, utilized to support bone mineralization in patients with renal impairment.

From$2.00/ capsuleView

Key takeaways

  • Bone pain, weakness or fractures can occur, but blood tests may become abnormal before symptoms develop.
  • Calcium, phosphate, parathyroid hormone, alkaline phosphatase, vitamin D and kidney stage must be interpreted together over time.
  • Active vitamin D is not automatically suitable; treatment depends on the pattern of mineral and hormone disturbance.

Catalogue matches do not diagnose bone-turnover type or set a safe mineral-management plan.

Why do the kidneys affect bone?

Kidneys regulate phosphate and activate vitamin D. As kidney function declines, secondary hyperparathyroidism and altered bone turnover may develop, alongside blood-vessel calcification risk.

How is treatment guided?

Care may adjust dietary phosphate, dialysis, phosphate binders or vitamin D pathways. Calcitriol has selected uses but can raise calcium or phosphate, so laboratory monitoring is essential. See bone health.

When to seek urgent care

Seek urgent assessment for a suspected fracture, sudden inability to bear weight, severe weakness, confusion, seizure or abnormal heart rhythm symptoms.